OPKO Health, Inc.
Nasdaq OPK · Miami, FL
Works in Genetic & rare · Hematology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Ophthalmology · Renal & urogenital · Respiratory · Women's health
OPKO Health, Inc. is a clinical trial sponsor based in Miami, FL, listed as Nasdaq OPK. It has 2 active clinical trials with 70 planned participants, across 10 therapeutic areas. Since 2021 it has completed 10 trials and stopped 5 early.
Trial track record · since 2021
Financials · Nasdaq OPK
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about OPKO Health, Inc
OPKO Health, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 70 planned participants, in Genetic & rare, Hematology, Infectious disease, Metabolic & endocrine and other areas. Since 2021 it has completed 10 trials and stopped 5 early.
OPKO Health, Inc is based in Miami, FL and is listed as Nasdaq OPK. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with OPKO Health, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-27.
Approve Suite is not affiliated with OPKO Health, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.